Mainak Bardhan: Our abstracts selected to be presented at SNO2024

Mainak Bardhan, Doctoral Researcher at the University of Miami Miller School of Medicine, shared a post on X:

“Elated to share our abstracts selected to be presented at SNO2024 in Houston, TX.”

“QLTI-17. Comparative analysis of lumbar puncture utility in diagnosis of primary versus secondary CNS lymphoma: A retrospective study”

“CNSC-62. Differential survival impact of trastuzumab deruxtecan in HER2-positive versus HER2-low breast cancer patients with brain metastases”

“DISP-19. Ethnic disparities in metastasis patterns and treatment utilization among metastatic breast cancer patients with brain metastases: A retrospective analysis of US health systems data (2019–2023)”

“BIOS-05. Peptide-based vaccines versus dendritic cell-based vaccine therapies for patients with glioblastoma: A network meta-analysis of controlled clinical trials”

“CTNI-32. A multicenter phase 1 trial of tucatinib, trastuzumab, and capecitabine with stereotactic radiosurgery in patients with brain metastases from HER2-positive breast cancer (TUTOR)”

More posts featuring Mainak Bardhan.

Mainak Bardhan is a Doctoral Researcher at the University of Miami Miller School of Medicine, specializing in the genetics, genomics, pathology, and epidemiology of neurological disorders, neuromuscular diseases, rare disorders, and infectious diseases. He serves as an Academic Editor for PLOS and BMC, and is a member of the editorial board for Sage.